The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C [beta] Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial.
The PKC-DRS Study Group *
[Miscellaneous Article] Diabetes. 54(7):2188-2197, July 2005.

(Format: HTML)